Their placenta-based cell therapy is being evaluated in two clinical trials these days, but the phase II in IC is currently on hold (safety). Two more phase II/III in CLI and Buerger's should start late this year.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.